Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Scientific Reports|March 18, 2015
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinomaQiu-Zhong Pan, Qi-Jing Wang, Jia-Qiang Dan, et al.
Cancer Genetics and Cytogenetics|April 25, 2006
Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31Jian-Chuan Xia, De-Sheng Weng, Jin-Tian Li, et al.
Annals of Surgical Oncology|July 30, 2013
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patientsKe Pan, Yong-Qiang Li, Wei Wang, et al.
Oncoimmunology|May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaJiang Li, Qiu-Yan Chen, Jia He, et al.
Clinical & Translational Immunology|March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 studyMeng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
Signal Transduction and Targeted Therapy|April 2, 2024
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trialQiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, et al.
Nature Medicine|July 16, 2025
The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trialDan-Yun Ruan, Hao-Xiang Wu, Su-Xia Luo, et al.
Pageof 21